Ordinary Rebalance | Solactive Obesity Index | Effective Date 1st August 2023
In the ordinary rebalance, the following index composition will be implemented effective open 01.08.2023:
MICROPORT SCIENTIFIC CORP |
I-SENS INC |
LIFETECH SCIENTIFIC CORP |
SD BIOSENSOR INC |
NOVAREX CO LTD |
SELVAS HEALTHCARE INC |
HUA MEDICINE |
OK BIOTECH CO LTD |
TAIDOC TECHNOLOGY CORP |
BIONIME CORP |
NIPRO (NISSHO) CORP ORD |
TCI CO LTD |
ADAPTHEALTH CORP |
ALTIMMUNE INC |
ANGIODYNAMICS INC |
ARTIVION INC |
N BROWN GROUP PLC |
CATO CORP-CLASS A |
CVRX INC |
DARIOHEALTH CORP |
DEXCOM INC |
EKF DIAGNOSTICS HOLDINGS PLC |
ESPERION THERAPEUTICS INC |
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED |
HERBALIFE LTD |
INSPIRE MEDICAL SYSTEMS INC |
IRHYTHM TECHNOLOGIES INC |
LEMAITRE VASCULAR INC |
LEXICON PHARMACEUTICALS INC |
MADRIGAL PHARMACEUTICALS INC |
MEDIFAST INC |
MANNKIND CORP |
NOVO NORDISK A/S |
ORAMED PHARMACEUTICALS INC |
INSULET CORP |
RESMED INC-CDI |
RHYTHM PHARMACEUTICALS INC |
SENSEONICS HOLDINGS INC |
TEVA PHARMACEUTICAL IND LTD |
TANDEM DIABETES CARE INC |
USANA HEALTH SCIENCES INC |
WW INTERNATIONAL INC |